Skip to main content
. 2016 Oct 4;113(42):11937–11942. doi: 10.1073/pnas.1613466113

Fig. S7.

Fig. S7.

Tumor-killing effect did not occur in HCC treated with either CHAL or TPZ alone. Gross morphology and histopathology examination of the liver and tumors in transient-CHAL–treated group (n = 2) (A) and TPZ-treated group (n = 2) (B), which were killed at day 21 after treatment, without detectable necrosis in the tumor regions (marked with dashed cycles). (Scale bars: 0.2 mm.)